
Ultivue
Expertise Partner
Ultivue seeks to give every patient the best chance of a cure by revealing the true state of cancer using spatial phenomics. Imagine a partner that supports your biomarker journey through the entire development pipeline, from the beginning, with defining and framing your specific scientific question, developing your biomarker panel, all the way through to delivering answers that enable your project to move forward and make an impact in personalized medicine.

Flagship Biosciences
Innovation Partner
Founded in 2009, Flagship Biosciences, Inc., is a technology-driven spatial biology and biomarker services company delivering the most accurate and informative data available. We are revolutionizing biomarker analysis to improve drug development and diagnostics using the power of AI with a consultative approach. Our services and technology improve on the data and interpretation from traditional methods, eliminating variability associated with typical biomarker assessments, and bringing new insights to analysis results. We provide expert scientific consultation for every client. Our team interprets results, contextualizes biology, and identifies the best course for success.

Stellaromics
Innovation Partner
Stellaromics is dedicated to pioneering breakthroughs in 3D spatial multi-omics. The company's mission is to empower researchers with cutting-edge tools that illuminate the complexities of biological systems, enabling groundbreaking discoveries that improve human health.

10x Genomics
Exhibition Partner
Best-in-class spatial data quality with complete coverage: The Visium platform delivers unbiased, whole transcriptome spatial gene expression analysis at single cell scale with unmatched spatial data quality and offers a flexible assay portfolio to study a broad range of tissues.

Element Biosciences
Exhibition Partner
Element Biosciences is advancing the future of drug discovery by enabling high-dimensional multiomic analysis through its next-generation AVITI24™ platform. Founded in 2017, Element is committed to empowering researchers with flexible, accessible, and high-performance sequencing technologies.
The AVITI24 platform integrates genomic, transcriptomic, proteomic, and cytoprofiling data into a single workflow—delivering a comprehensive view of cellular systems at single-cell resolution. Powered by Element’s proprietary Avidite™ chemistry, AVITI24 offers exceptional data quality, cost efficiency, and scalability to accelerate biomarker discovery, target validation, and therapeutic development.
With a mission to remove barriers to discovery, Element is helping scientists generate deeper insights into biology and uncover new possibilities for improving human health.
Learn more at www.elementbiosciences.com